Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibronectin type III domain containing 3C, pseudogene (FNDC3CP)
- Target
- FNDC3CP
- Molecular classification
- Pseudogene, noncoding RNA, does not encode a functional protein
01
Overview
FNDC3CP (Fibronectin type III domain containing 3C, pseudogene) is a human pseudogene identified on chromosome X. Pseudogenes are stretches of DNA that resemble functional genes but have lost their protein-coding potential due to disabling mutations such as frameshifts or premature stop codons. As a pseudogene, FNDC3CP is not transcribed or translated into a functional protein and is not considered a therapeutic target. Like other pseudogenes, it may participate in gene regulation as a source of noncoding RNA, but no specific biological or clinical role has been described for FNDC3CP. Pseudogenes can hinder genetic assays by causing PCR or gene annotation errors.
- Other names
- FNDC3CPfibronectin type III domain containing 3C, pseudogene
02
Mechanism of action
None. No drug mechanisms are reported for FNDC3CP
03
Biological functions
None established for FNDC3CP specifically.Pseudogenes in general may have regulatory RNA functions such as competing endogenous RNA activityserving as miRNA decoysor being processed into siRNAs with gene regulatory activities
04
Disease associations
No direct disease associations for FNDC3CP.Some pseudogenes participate in cancer or other diseases by regulating related protein-coding genes, but this is not established for FNDC3CP.
Beyond the preview
Go deeper on Fibronectin type III domain containing 3C, pseudogene (FNDC3CP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fibronectin type III domain containing 3C, pseudogene (FNDC3CP).